EGFR and non-small cell lung carcinoma: The clinically most important marker to date is the mutational status of the epidermal growth factor receptor (EGFR), which is a glycoprotein found in high density on the NSCLC cell surface, genetic mutations of which result in uncontrolled stimulation of cell proliferation.